Tag - FishFarmingExpert.com

Skip to main content

FishFarmingExpert

Customer Service

Categories

Subscribe

Close main menu

Benchmark gets go-ahead for double use of Ectosan baths

Benchmark gets go-ahead for double use of Ectosan baths

Aquaculture biotechnology company Benchmark has been granted permission to re-use the treatment water for its novel Ectosan Vet lice treatment for a second batch of fish.

Award nomination 'is a recognition for lice treatment efforts'

Award nomination 'is a recognition for lice treatment efforts'

The head of Benchmark Animal Health, John Marshall, has expressed his delight that the business has been shortlisted in the Aquaculture Awards, which will be presented at Aquaculture UK at Aviemore in May.

Benchmark orders third CleanTreat unit

Benchmark orders third CleanTreat unit

Aquaculture biotechnology company Benchmark Holdings has ordered a third CleanTreat filtration system for use with its novel lice treatment Ectosan Vet.

Benchmark strengthens lice treatment support team

Benchmark strengthens lice treatment support team

UK-headquartered aquaculture biotechnology company Benchmark Holdings has strengthened its Norway team to support the roll-out of its combined Ectosan Vet / CleanTreat sea lice bath treatment and water filtration unit.

Benchmark reduces losses as revenues rise

Benchmark reduces losses as revenues rise

Aquaculture health, genetics and nutrition company Benchmark increased revenue and adjusted EBITDA by 18% and 34% respectively in its 2021 financial year, reducing pre-tax losses to £9.2 million from £22.6m last year.

Full-year results will be better than market expects, says Benchmark

Full-year results will be better than market expects, says Benchmark

Aquaculture health, genetics and nutrition company Benchmark Holdings today said it expected full-year results to be significantly ahead of the current market consensus of £15.9 million.

Novel lice treatment gets green light for use in Norway

Novel lice treatment gets green light for use in Norway

The novel salmon lice treatment Ectosan Vet has been approved for use in Norway, its developer, Benchmark Holdings, announced today.

New lice treatment wins Norway marketing authorisation

New lice treatment wins Norway marketing authorisation

Aquaculture biotechnology company Benchmark today announced that is had received marketing authorisation from the Norwegian Medicines Agency (NoMA) for its novel lice treatment Ectosan Vet (BMK08) in Norway.